The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Open accessAbstract
Vascular smooth muscle cell (VSMC) proliferation and migration are responses to arterial injury that are highly important to the processes of restenosis and atherosclerosis.In the arterial balloon injury model in the rat, platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF) are induced in the vessel wall and regulate these VSMC activities.Novel insulin sensitizing agents, thiazolidinediones, have been demonstrated to inhibit insulin and epidermal growth factor-induced growth of VSMCs.We hypothesized that these agents might also inhibit the effect of PDGF and bFGF on cultured VSMCs and intimal hyperplasia in vivo.Troglitazone (1 M), a member of the thiazolidinedione class, produced a near complete inhibition of both bFGF-induced DNA synthesis as measured by bromodeoxyuridine incorporation (6.5 Ϯ 3.9 vs. 17.6 Ϯ 4.3% cells labeled, P Ͻ 0.05) and c-fos induction.This effect was associated with an inhibition (by 73 Ϯ 4%, P Ͻ 0.01) by troglitazone of the transactivation of the serum response element, which regulates c-fos expression.Inhibition of c-fos induction by troglitazone appeared to occur via a blockade of the MAP kinase pathway at a point downstream of MAP kinase activation by MAP kinase kinase.At this dose, troglitazone also inhibited PDGF-BB-directed migration of VSMC (by 70 Ϯ 6%, P Ͻ 0.01).These in vitro effects were operative in vivo.Quantitative image analysis revealed that troglitazone-treated rats had 62% ( P Ͻ 0.001) less neointima/media area ratio 14 d after balloon injury of the aorta compared with injured rats that received no troglitazone.These results suggest troglitazone is a potent inhibitor of VSMC proliferation and migration and, thus, may be a useful agent to prevent restenosis and possibly atherosclerosis.( J. Clin.Invest.1996.98:1897-1905.)Key words: restenosis • plateletderived growth factor • basic fibroblast growth factor • c-fos • MAP kinase Methods Materials.Materials were obtained from the following suppliers.PDGF-BB, DMEM, FBS, bromodeoxyuridine (BrdU), alkaline phosphatase-conjugated anti-mouse IgG antibody, monoclonal antibody against smooth muscle ␣ -actin, and myelin basic protein (MBP) were from Sigma Chemical Co.(St.Louis, MO).Culture plastic ware was from Falcon Labware (Lincoln Park, NJ).bFGF was from R&D Systems (Minneapolis, MN).Mouse anti-BrdU monoclonal antibody was from Zymed Laboratories, Inc. (South San Francisco, CA).Troglitazone and PD 98059 were a generous gift from Parke-Davis (Ann
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Experiments in molecular genetics
Miller, J. H. (1972) · Medical Entomology and Zoology · Cited by 27,157
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
The mitogen-activated protein kinase signal transduction pathway
Davis, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82362-6 · Cited by 2,139
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
Chen, R. H., Sarnecki, C., & Blenis, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.915 · Cited by 1,091
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Twentyman, P., & Luscombe, M. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.190 · Cited by 975
The Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Gille, H., Sharrocks, A. D., & Shaw, P. E. (1992) · Nature · doi:10.1038/358414a0 · Cited by 954
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
van de Loosdrecht, A. A., Beelen, R. H. J., Ossenkoppele, G. J., Broekhoven, M. G., & Langenhuijsen, M. M. A. C. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90034-5 · Cited by 821
Lindner, V, & Reidy, M. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3739 · Cited by 719
Jawien, A., Bowen-Pope, D. F., Lindner, V, Schwartz, S. M., & Clowes, A. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115613 · Cited by 674
ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.
Gille, H., Kortenjann, M., Thomae, O., Moomaw, C., Slaughter, C., Cobb, M. H., & Shaw, P. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07076.x · Cited by 664
Lenormand, P., Sardet, C., Pagès, G., L'Allemain, G., Brunet, A., & Pouysségur, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.1079 · Cited by 661
Insulin and Atheroma: 20-Yr Perspective
Stout, R. W. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.631 · Cited by 571
Role of basic fibroblast growth factor in vascular lesion formation.
Lindner, V, Lappi, D. A., Baird, A., Majack, R. A., & Reidy, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.106 · Cited by 517
Grotendorst, G. R., Seppä, H. E., Kleinman, H. K., & Martin, G. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3669 · Cited by 504
Fujiwara, T., Yoshioka, S., Yoshioka, T., Ushiyama, I., & Horikoshi, H. (1988) · Diabetes · doi:10.2337/diab.37.11.1549 · Cited by 473
Chang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M. (1995) · Science · doi:10.1126/science.7824950 · Cited by 446
PDGF ligand and receptor gene expression during repair of arterial injury.
Majesky, M. W., Reidy, M. A., Bowen-Pope, D. F., Hart, C. E., Wilcox, J. N., & Schwartz, S. M. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.5.2149 · Cited by 430
Peters, K. G., Marie, J., Wilson, E., Ives, H. E., Escobedo, J., Rosario, M. D., Mirda, D., & Williams, L. T. (1992) · Nature · doi:10.1038/358678a0 · Cited by 407
Sleigh, M. J. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90180-6 · Cited by 387
Journey to the surface of the cell: Fos regulation and the SRE.
Treisman, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00173.x · Cited by 373
Chang, M. W., Barr, E., Lu, M. M., Barton, K., & Leiden, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118281 · Cited by 354
Gonzalez, F., Seth, A., Raden, D., Bowman, D., Fay, F., & Davis, R. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.1089 · Cited by 321
Kakuta, T., Currier, J. W., Haudenschild, C. C., Ryan, T. J., & Faxon, D. P. (1994) · Circulation · doi:10.1161/01.cir.89.6.2809 · Cited by 311
Self-citationHarpold, M. M., Evans, R. M., Salditt-Georgieff, M., & Darnell, J. E. (1979) · Cell · doi:10.1016/0092-8674(79)90341-6 · Cited by 301
Zempo, N., Koyama, N., Kenagy, R. D., Lea, H. J., & Clowes, A. W. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.28 · Cited by 300
Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.
Sollott, S. J., Cheng, L., Pauly, R. R., Jenkins, G. M., Monticone, R. E., Kuzuya, M., Froehlich, J. P., Crow, M. T., Lakatta, E. G., & Rowinsky, E. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117867 · Cited by 253
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.
Buchanan, T. A., Meehan, W. P., Jeng, Y. Y., Yang, D., Chan, T. M., Nadler, J. L., Scott, S., Rude, R. K., & Hsueh, W. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118041 · Cited by 238
Self-citationMetabolic effects of troglitazone on fructose-induced insulin resistance in the rat
Lee, M. K., Miles, P. D., Khoursheed, M., Gao, K. M., Moossa, A. R., & Olefsky, J. M. (1994) · Diabetes · doi:10.2337/diabetes.43.12.1435 · Cited by 194
Iwamoto, Y., Kuzuya, T., Matsuda, A., Awata, T., Kumakura, S., Inooka, G., & Shiraishi, I. (1991) · Diabetes Care · doi:10.2337/diacare.14.11.1083 · Cited by 193
Kortenjann, M., Thomae, O., & Shaw, P. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4815 · Cited by 179
Jarrett, R. J., & Shipley, M. J. (1988) · Diabetologia · doi:10.1007/bf00274775 · Cited by 168
Metabolic Effects of Troglitazone on Fructose-Induced Insulin Resistance in the Rat
Lee, M.-K., Miles, P. D. G., Khoursheed, M., Gao, K., Moossa, A. R., & Olefsky, J. M. (1994) · Diabetes · doi:10.2337/diab.43.12.1435 · Cited by 141
Banskota, N. K., Taub, R. A., Zellner, K., & King, G. L. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1183 · Cited by 132
Miano, J. M., Vlasic, N., Tota, R. R., & Stemerman, M. B. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.211 · Cited by 130
Signal integration at the c-fos promoter
Janknecht, R., Cahill, M. A., & Nordheim, A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.3.443 · Cited by 128
Pioglitazone Increases Insulin Sensitivity by Activating Insulin Receptor Kinase
Kobayashi, M., Iwanishi, M., Egawa, K., & Shigeta, Y. (1992) · Diabetes · doi:10.2337/diab.41.4.476 · Cited by 127
Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats
Dubey, R. K., Zhang, H. Y., Reddy, S. R., Boegehold, M. A., & Kotchen, T. A. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.4.r726 · Cited by 119
Simons, M., Edelman, E. R., & ROSENBERG, R. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117240 · Cited by 117
Pauly, R. R., Bilato, C., Sollott, S. J., Monticone, R. E., Kelly, P. T., Lakatta, E. G., & Crow, M. T. (1995) · Circulation · doi:10.1161/01.cir.91.4.1107 · Cited by 114
Savage, P. J. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00008 · Cited by 111
Berkowitz, K. M., Peters, R., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A. H., Azen, S. P., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1572 · Cited by 108
Effects of ciglitazone on blood pressure and intracellular calcium metabolism.
Pershadsingh, H. A., Szöllõsi, J., Benson, S., Hyun, W. C., Feuerstein, B. G., & Kurtz, T. W. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.1020 · Cited by 92
Sandouk, T., Reda, D. J., & Hofmann, C. A. (1993) · Endocrinology · doi:10.1210/endo.133.1.8319581 · Cited by 90
Bilato, C., Pauly, R. R., Melillo, G., Monticone, R. E., Gorelick-Feldman, D. A., Gluzband, Y. A., Sollott, S. J., Ziman, B. D., Lakatta, E. G., & Crow, M. T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118236 · Cited by 87
Phosphorylation-Dependent Formation of a Quaternary Complex at the c- fos SRE
Gille, H., Kortenjann, M., Strahl, T., & Shaw, P. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1094 · Cited by 64
Parker, T. G., Chow, K. L., Schwartz, R. J., & Schneider, M. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50737-2 · Cited by 59
Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats
Iwanishi, M., & Kobayashi, M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90016-h · Cited by 55
Evidence for a Direct Vascular Effect
Buchanan, T. A., Meehan, W. P., Jeng, Y. Y., Yang, D. G., Chan, T. M., Nadler, J. L., Scott, S. D., Rude, R. K., & Hsueh, W. A. (1995) · Cited by 50
Self-citationInsulin resistance and macrovascular disease
Hsueh, W. A., Law, R. E., Saad, M. F., Dy, J., Feener, E. P., & King, G. (1996) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199608000-00010 · Cited by 14
Self-citation
Cited by
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Metadata
- Authors
- Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., & Hsueh, W. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-10-15
- Volume
- 98
- Issue
- 8
- Pages
- 1897-1905
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2090412760
- Cited by
- 476
- References
- 58
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.